Malignant lymphomas of children are among the pathologies which have benefited the most of the improvements of therapy since twenty years. Classically, the therapy of Hodgkin lymphoma included radiotherapy; nowadays, the role of chemotherapy becomes more important. For non-Hodgkin lymphomas, the role of surgery and radiotherapy has quite completely disappeared, and the tumors are cured by chemotherapy. This review will focus on Hodgkin lymphoma, and two of the most frequent non-Hodgkin lymphomas, namely Burkitt lymphoma and lymphoblastic lymphoma. Most recent advances in treatment and management of sequelae are presented.